SCHEMBL31744580

SCHEMBL31744580

Fc1ccccc1Oc1c[nH]c2ccc(Br)cc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.48
GPR84 Q9NQS5 1/20 0.44
HTR2A P28223 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.43
NR4A2 P43354 1/20 0.40
TRPA1 O75762 1/20 0.40
HTR1A P08908 6/20 0.40
SLC6A2 P23975 4/20 0.40
SLC6A3 Q01959 2/20 0.40
CSNK2A1 P68400 1/20 0.39
SLC6A4 P31645 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39
TUBB2A Q13885 1/20 0.39
TUBB8 Q3ZCM7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31744680 0.85 IDO1 (0.50) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744712 0.84 IDO1 (0.49) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744693 0.84 TRPA1 (0.49) IDO1GPR84HTR2ATRPM8TRPA1
SCHEMBL31744643 0.82 IDO1 (0.51) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744877 0.82 IDO1 (0.48) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744707 0.82 IDO1 (0.45) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744902 0.81 IDO1 (0.47) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744648 0.81 HTR1A (0.45) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744596 0.80 IDO1 (0.48) IDO1GPR84HTR2ATRPM8NR4A2
SCHEMBL31744809 0.80 KIF11 (0.44) IDO1TRPA1HTR1ASLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US claimed
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CFD RES CORPORATION (US) 2025-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382269-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 IDO1 38/4885GPR84 4183/4885HTR2A 4846/4885
US-20250382268-A1 METHODS AND COMPOSITIONS FOR SELECTIVELY INHIBITING PATHOGENIC MICROBES CD14, MIF, NOD2 IDO1 38/4885GPR84 4183/4885HTR2A 4846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.